Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.
about
Treatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and VomitingSymptom management in the older adult: 2015 updateMe, TooCheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting.Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.Effect of Persian Medicine Remedy on Chemotherapy Induced Nausea and Vomiting in Breast Cancer: A Double Blind, Randomized, Crossover Clinical Trial.Olanzapine for the Prevention of Chemotherapy-Induced Nausea and VomitingThe safety of olanzapine in young children: a systematic review and meta-analysis.Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.Psychopharmacology in cancer.Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.Newest Drugs for Chronic Unexplained Nausea and Vomiting.2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.Investigational drug therapies for the treatment of gastroparesis.Use of olanzapine for the relief of nausea and vomiting in patients with advanced cancer: a multicenter survey in Japan.Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy.Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study.A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future ResearchOlanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung cancer
P2860
Q26784070-CB4A0FAA-94F3-4938-9A36-D5F01A41E7E2Q30374202-DE9CD83E-2A9D-4584-AF46-E971C16E77A7Q33866095-303DD8DC-0DF2-4B00-878E-055856F75F98Q33866119-D5F7F338-A5CA-4781-8603-C928EE7F87AAQ35898479-064F931D-66C1-4CF0-8006-9F153FCD33A7Q37641334-23C21C96-D196-4050-BBC7-68ADB95AB288Q37691654-D1CDB149-67E7-402B-BE02-54CC55468D41Q38242011-BC0D185B-270B-4AA0-BB36-8F16F9E07E2DQ38260952-3DBA5D86-01A0-4879-B1BE-000B4EB65195Q38270608-AED039B8-ACDE-42FB-B4E3-63EC5E948C98Q38574240-EFB2C944-DE17-45CC-A95B-EAF544A916E1Q38696953-90C1BCBC-6BF3-4B1B-8F15-E0ECC8E13217Q38977503-63D0D284-62DD-4283-AAEF-414588D4BD56Q38999263-E6DFEB12-05A6-4DBB-AC27-70EF1AE73F98Q39106195-9C95358A-F258-418E-BCBA-54FC0B0662B9Q39177188-48AF9E18-4080-4F50-B268-98E0C5416EBEQ40542547-962332A6-CB33-4FEF-9674-77DB9B2D2632Q47296270-55692680-3668-46C0-AA74-43CEF95E76B8Q53828936-A88279D9-DE5E-4DA7-AD68-0F8DDDB894A4Q57161235-BFFAB70F-5A27-438A-931C-34D002B96A83Q58739404-094E865C-767F-4BA8-A633-843A779730EF
P2860
Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.
@en
type
label
Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.
@en
prefLabel
Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.
@en
P2860
P1476
Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review
@en
P2093
Christopher M Hocking
P2860
P2888
P304
P356
10.1007/S00520-014-2138-Y
P577
2014-02-13T00:00:00Z